Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03443180 · ClinicalTrials.gov registry record · NA
Gluten and Amylase Trypsin Inhibitors (ATI) Free Diet
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03443180 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 32 participants.
The verdict
NCT03443180, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Siblings of those with type 1 diabetes are at an increased risk of developing the disease themselves. Through prior research, the investigators have found that siblings as well as those with type 1 diabetes have a general level of inflammation in the body. The investigators are examining the role that diet plays in this level of inflammation by asking siblings of children with type 1 diabetes to go on a gluten and Amylase Trypsin Inhibitors (ATI)-free diet for 4 weeks. Blood and stool samples will be measured before the diet, after the diet is completed and again 4 weeks after participants resume their normal diet.
Interventions
- OTHER Gluten and Amylase Trypsin Inhibitors (ATI)-free diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2020-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03443180
The ClinicalTrials.gov registry entry for NCT03443180 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gluten and Amylase Trypsin Inhibitors (ATI)-free diet is the first listed.
NCT03443180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03443180 about?
NCT03443180 is a clinical study titled "Gluten and Amylase Trypsin Inhibitors (ATI) Free Diet". Siblings of those with type 1 diabetes are at an increased risk of developing the disease themselves. Through prior research, the investigators have found that siblings as well as those with type 1 diabetes have a general level of inflammation in the body. The investigators are examining the role th...
What is the current status of trial NCT03443180?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-01-01. Estimated completion is 2020-03-09.
What interventions are being tested in trial NCT03443180?
The interventions under investigation include: Gluten and Amylase Trypsin Inhibitors (ATI)-free diet (OTHER).
Who is sponsoring clinical trial NCT03443180?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.